Any general news stories or articles in the media we believe are of interest to you
Do you shop on Amazon UK?
Now you can help CML Support, who runs this web site, every time you order a new book, buy a present, or stock up on household items. Simply start your shopping experience at: http://smile.amazon.co.uk and select "Chronic Myeloid Leukaemia Support Group" as your preferred charity, and we will receive 0.5% of every purchase you make.
What is AmazonSmile and how does it work?
The evidence that vitamin D has important health benefits continued to increase in 2021. In particular, the benefits in reducing risk of SARS-CoV-2 infection and COVID-19 became more robust, as did those for CVD. The evidence clearly points to the healthy range of 25(OH)D as being 30-40 ng/ml, with additional evidence for the optimal range being 40-60 ng/ml. Due to modern lifestyles, it is very difficult to achieve those levels from solar UVB exposure and diet. The most efficient way to raise serum 25(OH)D is to supplement with vitamin D3, of at least 5000 IU/d, and up to 10,000 IU/d.
What is D*action?
D*action started out as a 5 year (now on-going) public health project to provide education and research to SOLVE the vitamin D deficiency epidemic, by measuring vitamin D serum levels, collecting health data from participants, and tracking the health effects of getting to levels of 40-60 ng/ml (100-150 nmol/L).
Published by GrassrootsHealth Nutrient Research Institute
MyeloidScan – Long COVID in patients with myeloid blood cancers
Have you had COVID 19 infection? We need to find out more about long covid affects people like you – can you help us?
We would like to share with you an opportunity to take part in a study to investigate the impact of COVID-19 infection in people with myeloid blood cancers.
What is the study for?
A really interesting paper on the management and incidence of COVID-19 in CML patients in Italy
https://www.nature.com/articles/s41375-020-0904-z.pdf
As the UK and the world see many more people test positive for COVID-19 You can help collect important data with this free symptom tracker by monitoring your day to day health and wellbeing.  
It is important to note that the questions and answers below refer to chronic phase CML. Management of accelerated phase, blast crisis or post-transplant should be discussed in detail with the clinical team.
CML EHA SWG 29 MARCH 2020
CML, TKI treatment and COVID-19 disease
Dr Delphine Rea, Saint-Louis University Hospital, Paris, France and Professor Rudiger Hehlmann, ELN/EHA-SWG for CML
iCMLf only want to hear from patients who have had COVID-19 confirmed by a laboratory test. If you have had symptoms consistent with COVID-19 but have not had it confirmed by a test, please do not get in touch with them and use their valuable time.
Note: CODVID-19 Virus request from International CML Foundation
CML and COVID-19 case collection
Dr Michael Deininger (USA), Dr François Guilhot (France), Dr Jeroen Janssen (Netherlands), Dr Tim Hughes (Australia), Dr Jeffrey Lipton (Canada), Dr Franck Nicolini (France), Dr Jerry Radich (USA), Dr Delphine Rea (France), Dr Giuseppe Saglio (Italy), Dr Suzanne Saussele (Germany), Dr Rick Silver (USA), Dr Juan-Luis Steegmann (Spain)